Elba Etchebehere

12PUBLICATIONS
40CO-AUTHORS
PharmacogenomicsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersPsycholinguistics (incl. speech production and comprehension)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 09, 2026
Insights from PSMAfore: impact on health-related quality of life.

Caroline Torricelli, Natália Tobar, André Sasse

|Apr 23, 2025
Brazilian profile of Radium-223 in metastatic prostate cancer: a multicentric, retrospective study.

Stephan Souza, Felipe Ribeiro, Ana Brito

|Nov 27, 2024
Theranostics Nuclear Medicine in Prostate Cancer.

Helena Lima, Marina Etchebehere, Mateos Bogoni

|Oct 25, 2024
Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.

Ludmila Santiago Almeida, Irene García Megías, Elba Cristina Sá Camargo Etchebehere

|Nov 02, 2022
Interictal and postictal 18F-FDG PET/CT in epileptogenic zone localization.

Marcela Santos Carvalho, Marina Koutsodontis Machado Alvim, Elba Etchebehere

|Oct 04, 2021
The ratio between the whole-body and primary tumor burden, measured on 18F-FDG PET/CT studies, as a prognostic indicator in advanced non-small cell lung cancer.

Felipe Renê Alves Oliveira, Allan de Oliveira Santos, Mariana da Cunha Lopes de Lima

Pageof 2

Frequent Collaborators

5 joint publications

Allan O Santos

2 joint publications

Bárbara Juarez Amorim

2 joint publications

Celso Dario Ramos

1 joint publications

Janaina B S Ricciardi